Skip to main content
. 2022 Jan 29;12(2):347. doi: 10.3390/diagnostics12020347

Table 1.

Demographics of patients with prior breast cancer having incidental ovarian tumors.

All Ovary Malignancy Ovary Benign p-Value
(n = 60) (n = 11) (n = 49)
Age, median (year) 46 (24, 72) 51 (32, 60) 45 (24, 72) 0.203
Breast pathology 0.390
Invasive ductal carcinoma 52 9 (81.8%) 43 (87.8%)
Lobular carcinoma 3 1 (9.1%) 2 (4.1%)
Mucinous adenocarcinoma 2 0 (0.0%) 2 (4.1%)
Malignant phyllodes tumor 1 0 (0.0%) 1 (2.0%)
Papillary carcinoma 1 0 (0.0%) 1 (2.0%)
Angiosarcoma 1 1 (9.1%) 0 (0.0%)
Morphology 0.000
Solid or solid-cystic 11 11 (100.0%) 1 (2.0%)
Cystic 49 0 (0.0%) 48 (98.0%)
Laterality 0.154
Bilateral 8 3 (27.3%) 5 (10.2%)
Unilateral 52 8 (72.7%) 44 (89.8%)
Interval, median (month) 27 (0, 140) 8 (0, 42) 29 (1, 140) 0.044
T stage 0.345
3–4 9 3 (27.3%) 6 (12.2%)
1–2 51 8 (72.7%) 43 (87.8%)
N stage 1.000
123 24 4 (36.4%) 20 (40.8%)
0 36 7 (63.6%) 29 (59.2%)
M stage 0.003
1 8 5 (45.5%) 3 (6.1%)
0 52 6 (54.5%) 46 (93.9%)

Note—Numbers in parentheses are ranges or percentage. p-value based on Mann-Whitney test/Fisher Exact.